Investing.com - J&J (NYSE:JNJ) reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
J&J announced earnings per share of $2.3 on revenue of $20.69B. Analysts polled by Investing.com anticipated EPS of $1.99 on revenue of $19.86B. That with comparison to EPS of $2.1 on revenue of $20.02B in the same period a year before.J&J had reported EPS of $1.88 on revenue of $20.75B in the previous quarter.Analysts are expecting EPS of $1.91 and revenue of $19.65B in the upcoming quarter.
J&J shares are down 4% from the beginning of the year and are trading at $139.77 , down-from-52-week-high.They are outperforming the S&P 500 which is down 14.89% year to date.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by Baxter on Tuesday, March 17, 2020, who reported EPS of $0.97 on revenue of $3.04B, compared to forecasts EPS of $0.89 on revenue of $3.04B.
Biontech had missed expectations on Tuesday, March 31, 2020 with first quarter EPS of $-0.27 on revenue of $30.72M, compared to forecast for EPS of $-0.19 on revenue of $33.28M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar